C12N 2760/14071
Demonstrated in vivo effect
C12N2760/14071 (Demonstrated in vivo effect) appears on 2 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 4
- Assignees
- 2
- Inventors
- 4
- Latest grant
- 16 Apr 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 2 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
By publication year.
Recent patents
- Immune activation triggered by filovirus proteins and polypeptides10 Jun 2021US 2021/0171581 A1University of Hawaii
- Compositions and methods for the treatment of viral infections18 Aug 2016US 2016/0237123 A1Dana-Farber Cancer Institute, Inc.
- Compositions and methods for the treatment of viral infections2 Jun 2016US 2016/0152667 A1Dana-Farber Cancer Institute, Inc.
- Compositions and methods for the treatment of viral infections29 Dec 2011US 2011/0318352 A1Dana-Farber Cancer Institute, Inc.
Most cited
By later US patents